Hospitals could earn more for buying US-made drugs, CMS proposes
The Trump administration's Centers for Medicare & Medicaid Services is looking to incentivize hospitals to buy more domestically-produced drugs.
Under a proposed rule, hospitals purchasing more than 50% of domestic-made essential ...
⚠️ 风险分析 中
摘要：美国CMS提议激励医院购买国产药物，可能影响跨国医药供应链。
影响：该政策可能增加非美国制药企业的市场准入壁垒，影响其在美国医院的销售，并可能引发贸易争端或制裁风险。
建议：医药企业应评估供应链本土化需求，关注贸易政策变化，并考虑调整市场策略以应对潜在出口管制影响。
「素履以往」
Not the sharpest mind, but the steadiest hand.
Not the sharpest mind, but the steadiest hand.